However, the use of long-acting granulocyte-colony stimulating factor (G-CSF) as secondary prophylaxis proved to be highly effective, ensuring that no patients were unable to complete the neoadjuvant treatment due to neutropenia. Here, CSF3 is linked to neutropenia.